- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Theses and Dissertations /
- Study of dose escalation protocols in prostate cancer...
Open Collections
UBC Theses and Dissertations
UBC Theses and Dissertations
Study of dose escalation protocols in prostate cancer radiation therapy with patient realignment by using internal fiducial markers Zhang, Miao
Abstract
Use of internal fiducial markers and electronic portal imaging (EPID) to realign patients has been shown to significantly reduce positioning uncertainties in prostate radiation treatment. This creates the possibility of improving the treatment by decreasing the planning target volume (PTV) margin added on the clinical target volume (CTV), which in turn may allow dose escalation. As a first step we do test on 3 patients. Conformal treatment plans for 3 prostate cancer patients were evaluated by using different PTV margins with dose prescription of 70Gy/35fr initially. Two beam arrangements, 4-Field-Box (4FB) and 4-Field-Oblique (4FO), were used. Then, two dose escalation schemes, 74Gy and 78Gy, with tighter prescribed PTV margins chosen from the first simulation were tested. A Monte Carlo model was developed to simulate the daily organ motion and calculate the dose to organs. After the whole treatment, dose-volume histograms were produced and tumour control probability (TCP), equivalent uniform dose (EUD) and the effective dose to critical organs (Deff) were calculated. By comparing the biological factors, optimized dose escalation schemes were found. The results show that using internal fiducial markers and EPID, the prescription dose can be escalated to 78Gy/37fr with a 4mm PTV margin. Based on the available dose-response data for intermediate ' risk prostate patients this is estimated to result in a 20% increase of TCP and significantly reduced rectal complications. From these results, another test on 20 patients was performed to test the general validity of the dose escalation, which counts the second step of this project. We compared the outcome of two plans: one is 70Gy/35fr, 10mm PTV margin and without patient realignment (Reference Plan) and another is 78Gy/39fr, 5mm PTV margin with patient realignment (Escalated Plan). Four-field-oblique (gantry angles 35°, 90°, 270°, 325°) beam arrangement was used. Using the same method described before. Results show that for intermediate risk prostate patients by using dose escalation to 78Gy/39fr with a 5mm PTV margin will provide a 20% increase of local control and significantly reduced rectal complications.
Item Metadata
Title |
Study of dose escalation protocols in prostate cancer radiation therapy with patient realignment by using internal fiducial markers
|
Creator | |
Publisher |
University of British Columbia
|
Date Issued |
2005
|
Description |
Use of internal fiducial markers and electronic portal imaging (EPID) to realign patients has been
shown to significantly reduce positioning uncertainties in prostate radiation treatment. This
creates the possibility of improving the treatment by decreasing the planning target volume
(PTV) margin added on the clinical target volume (CTV), which in turn may allow dose
escalation. As a first step we do test on 3 patients. Conformal treatment plans for 3 prostate
cancer patients were evaluated by using different PTV margins with dose prescription of
70Gy/35fr initially. Two beam arrangements, 4-Field-Box (4FB) and 4-Field-Oblique (4FO),
were used. Then, two dose escalation schemes, 74Gy and 78Gy, with tighter prescribed PTV
margins chosen from the first simulation were tested. A Monte Carlo model was developed to
simulate the daily organ motion and calculate the dose to organs. After the whole treatment,
dose-volume histograms were produced and tumour control probability (TCP), equivalent
uniform dose (EUD) and the effective dose to critical organs (Deff) were calculated. By
comparing the biological factors, optimized dose escalation schemes were found. The results
show that using internal fiducial markers and EPID, the prescription dose can be escalated to
78Gy/37fr with a 4mm PTV margin. Based on the available dose-response data for intermediate '
risk prostate patients this is estimated to result in a 20% increase of TCP and significantly
reduced rectal complications. From these results, another test on 20 patients was performed to
test the general validity of the dose escalation, which counts the second step of this project. We
compared the outcome of two plans: one is 70Gy/35fr, 10mm PTV margin and without patient
realignment (Reference Plan) and another is 78Gy/39fr, 5mm PTV margin with patient
realignment (Escalated Plan). Four-field-oblique (gantry angles 35°, 90°, 270°, 325°) beam
arrangement was used. Using the same method described before. Results show that for
intermediate risk prostate patients by using dose escalation to 78Gy/39fr with a 5mm PTV
margin will provide a 20% increase of local control and significantly reduced rectal
complications.
|
Genre | |
Type | |
Language |
eng
|
Date Available |
2009-12-22
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
|
DOI |
10.14288/1.0085234
|
URI | |
Degree | |
Program | |
Affiliation | |
Degree Grantor |
University of British Columbia
|
Graduation Date |
2005-11
|
Campus | |
Scholarly Level |
Graduate
|
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.